ASX:EAF

Evans & Partners Asia Fund (EAF) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
175,573 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EAF stock logo

About Evans & Partners Asia Fund Stock (ASX:EAF)

EAF Stock News Headlines

Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Claremont Global Fund (0P0001349P)
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Petershill Partners Guides for Stable 2024
Medalist Partners Short Duration Fund;Inv
Public Asia Ittikal Fund (0P00008MHX)
Asia hedge fund startups raised just $3.5 bln in 2022
Baron Partners Fund;Retail
Download Morningstar’s Fund Flows Commentary
See More Headlines
Receive EAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evans & Partners Asia Fund and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

EAF Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Evans & Partners Asia Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evans & Partners Asia Fund investors own include Sangamo Therapeutics (SGMO), ZIOPHARM Oncology (ZIOP), General Electric (GE), EPR Properties (EPR), Caterpillar (CAT), BioSig Technologies (BSGM), BP (BP) and Bristol-Myers Squibb (BMY).

This page (ASX:EAF) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners